# FDA Inspection 1219061 - Alexion Pharmaceuticals, Inc. - September 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/abdcc104-3e67-42ba-8233-8fd8428ad075
Source feed: FDA_Inspections

> FDA Inspection 1219061 for Alexion Pharmaceuticals, Inc. on September 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219061
- Company Name: Alexion Pharmaceuticals, Inc.
- Inspection Date: 2023-09-14
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1262947 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/5fb2d391-dc92-43ec-a7a3-bbb58a161055)
- [FDA Inspection 1262947 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/deefafb0-cf26-41b8-a8f2-e29bc44947cf)
- [FDA Inspection 1254018 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/5b301914-bf94-449d-9b3e-8f8c86990b4e)
- [FDA Inspection 1254018 - 2024-11-07](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/27326ddb-c4b0-4290-b6d1-c15f6fbaccc0)
- [FDA Inspection 1218199 - 2023-06-30](https://www.keypedia.com/records/fda_inspections/alexion-pharmaceuticals-inc/87273935-9a17-4dea-8026-1d898891241f)

Company: https://www.keypedia.com/companies/alexion-pharmaceuticals-inc/ff74d8e2-db98-41ca-9f7b-b8e9cb8b4015

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c